Skip to main content
Clinical Trials/KCT0002356
KCT0002356
Completed
未知

A multicenter, non-interventional observational study to evaluate 1-year clinical outcomes in acute coronary syndrome (ACS) patients undergoing percutaneous coronary interventions (PCI) and Prasugrel therapy.

Daiichi-Sankyo Korea0 sites3,213 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Diseases of the circulatory system
Sponsor
Daiichi-Sankyo Korea
Enrollment
3213
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
September 30, 2020
Last Updated
4 years ago
Study Type
Observational Study
Sex
All

Investigators

Sponsor
Daiichi-Sankyo Korea

Eligibility Criteria

Inclusion Criteria

  • 1\) over 19 year
  • 2\) Acute coronary syndrome\-Percutaneous Coronary Intervention patients treated with prasugrel according to the labeled indication
  • 3\) Patients who initiate or switch to prasugrel within 6 months after Percutaneous Coronary Intervention
  • 4\) Patients who gie voluntary written informed consent to participate in the study

Exclusion Criteria

  • 1\) Patients who are not simultaneously participating in interventional study administering of antiplatelet agents except prasugrel/antithrombotic agents

Outcomes

Primary Outcomes

Not specified

Similar Trials